Four Breakthrough Opportunities
Each company addresses a critical gap in healthcare or infrastructure with differentiated deep tech and clear paths to market.
Cloud-native evidence operating system and roll-up platform for radiology and advanced imaging clinics. Combines New Hope Life Scan anchor asset with proprietary Careview software for standardized, high-value medical evidence production.
Patient-owned maternal health record platform. 84% of maternal deaths are preventable with better data continuity. Materna creates a portable, secure pregnancy record that follows mothers across all providers and state lines.
Real-time AI-powered surgical guidance system with nerve detection. 44% of surgical nerve injuries go unrecognized during procedures. NeuraSense provides surgeons with live tissue mapping and safety alerts.
Edge AI infrastructure for parking, security, and real estate monitoring. Zero-latency on-device processing with 99% accuracy. Early pilot deployments with strong municipal and automotive interest.
Capital Allocation
Distribution across portfolio companies
| Company | Stage | Amount | Allocation | Status |
|---|---|---|---|---|
Sigma HealthSense |
Seed | $750,000 | ● Pilot Active | |
Materna Health |
Pre-Seed | $750,000 | ● LOIs Secured | |
NeuraSense Labs |
Seed | $1,500,000 | ● Pre-Clinical | |
ParkSense AI |
Seed | $1,500,000 | ● Deployed |
